GLENN LEVINE

Concepts (334)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Platelet Aggregation Inhibitors
23
2022
284
5.040
Why?
Percutaneous Coronary Intervention
17
2022
295
3.620
Why?
American Heart Association
29
2025
329
3.550
Why?
Coronary Artery Disease
20
2024
889
3.380
Why?
Cardiology
31
2025
521
3.350
Why?
Myocardial Infarction
16
2025
1102
2.840
Why?
Practice Guidelines as Topic
20
2020
1334
2.650
Why?
Angioplasty, Balloon, Coronary
18
2016
184
2.620
Why?
Cardiovascular Diseases
20
2025
2090
2.570
Why?
ST Elevation Myocardial Infarction
7
2020
121
1.890
Why?
Societies, Medical
15
2019
776
1.860
Why?
Acute Coronary Syndrome
11
2021
238
1.850
Why?
Aspirin
4
2021
231
1.560
Why?
Myocardial Ischemia
9
2022
365
1.540
Why?
Advisory Committees
10
2021
158
1.470
Why?
Stress, Psychological
5
2025
601
1.340
Why?
Thrombosis
6
2022
539
1.290
Why?
Meditation
2
2020
19
1.220
Why?
United States
48
2025
11684
1.120
Why?
Purinergic P2Y Receptor Antagonists
3
2021
47
1.110
Why?
Coronary Disease
12
2025
721
1.110
Why?
Research Report
5
2021
78
1.090
Why?
Pets
2
2020
17
1.080
Why?
Cardiac Catheterization
13
2022
664
0.960
Why?
Humans
113
2025
133564
0.860
Why?
Pessimism
1
2022
5
0.810
Why?
Electrocardiography
10
2020
1006
0.780
Why?
Fibrinolytic Agents
8
2019
203
0.770
Why?
Mental Health
2
2025
372
0.730
Why?
Warfarin
1
2022
125
0.720
Why?
Angina, Unstable
5
2014
55
0.710
Why?
Mind-Body Therapies
1
2021
12
0.710
Why?
Erectile Dysfunction
1
2024
209
0.700
Why?
Stroke
5
2022
1070
0.700
Why?
Sexual Behavior
2
2014
250
0.700
Why?
Yoga
1
2020
12
0.670
Why?
Ownership
1
2020
35
0.650
Why?
Cardiac Rehabilitation
1
2020
29
0.650
Why?
Disease Management
4
2016
562
0.630
Why?
Androgen Antagonists
2
2010
133
0.620
Why?
Cerebrovascular Disorders
1
2019
126
0.610
Why?
Heart Diseases
2
2022
522
0.590
Why?
Risk Factors
21
2025
11098
0.580
Why?
Evidence-Based Medicine
7
2025
678
0.570
Why?
Graft Occlusion, Vascular
1
2017
93
0.540
Why?
Safety
2
2008
218
0.530
Why?
Stents
6
2017
877
0.530
Why?
Enoxaparin
6
2010
43
0.530
Why?
Secondary Prevention
2
2017
224
0.520
Why?
Coronary Artery Bypass
6
2019
532
0.520
Why?
Angina Pectoris
4
2022
67
0.500
Why?
Consensus
6
2025
738
0.500
Why?
Primary Prevention
1
2017
179
0.500
Why?
Hypertension
3
2020
1397
0.490
Why?
Vascular Surgical Procedures
1
2020
559
0.480
Why?
Heparin, Low-Molecular-Weight
3
2006
25
0.470
Why?
Heart
1
2019
749
0.450
Why?
Diabetes Mellitus
2
2020
934
0.440
Why?
Anticoagulants
7
2022
600
0.430
Why?
Perioperative Care
1
2016
219
0.420
Why?
Quality Indicators, Health Care
3
2025
232
0.420
Why?
Myocardial Revascularization
3
2018
108
0.400
Why?
Quality Improvement
4
2025
692
0.380
Why?
Risk Assessment
11
2022
3700
0.370
Why?
Randomized Controlled Trials as Topic
7
2019
1211
0.360
Why?
Renal Insufficiency, Chronic
1
2020
806
0.360
Why?
Microcirculation
2
2022
117
0.340
Why?
Prostatic Neoplasms
2
2010
1623
0.340
Why?
Treatment Outcome
20
2025
12988
0.340
Why?
Professionalism
2
2021
52
0.340
Why?
Guideline Adherence
4
2020
395
0.310
Why?
Time-to-Treatment
2
2020
201
0.300
Why?
Thrombolytic Therapy
4
2020
208
0.300
Why?
Clinical Competence
5
2013
1063
0.300
Why?
Brain
1
2019
3226
0.270
Why?
Coronary Angiography
7
2020
483
0.270
Why?
Heart Valve Prosthesis Implantation
3
2021
452
0.270
Why?
Heart Valve Diseases
2
2021
181
0.270
Why?
Cats
2
2020
126
0.270
Why?
Thoracic Surgery
3
2014
162
0.260
Why?
Prostheses and Implants
1
2008
151
0.260
Why?
Ticlopidine
2
2017
30
0.250
Why?
Magnetic Resonance Imaging
2
2008
3843
0.250
Why?
Dogs
2
2020
798
0.240
Why?
Thrombectomy
2
2016
104
0.230
Why?
Maternal Health
1
2025
24
0.230
Why?
Perinatal Care
1
2025
68
0.220
Why?
Acute Disease
7
2007
1190
0.220
Why?
Heart Valve Prosthesis
4
2021
309
0.220
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
5
2006
64
0.210
Why?
Endothelium, Vascular
2
2017
522
0.210
Why?
Drug Therapy, Combination
4
2022
1197
0.210
Why?
Intraoperative Care
1
2003
120
0.200
Why?
Europe
7
2019
380
0.200
Why?
No-Reflow Phenomenon
2
2019
9
0.200
Why?
Employment
2
2020
71
0.200
Why?
Male
23
2024
65798
0.200
Why?
Aortic Valve
3
2015
457
0.200
Why?
Vitamin K
1
2022
37
0.200
Why?
Cardiac Imaging Techniques
2
2012
29
0.190
Why?
Glomerular Filtration Rate
2
2020
549
0.190
Why?
Folklore
1
2022
1
0.190
Why?
Educational Status
2
2020
297
0.190
Why?
Patient Care Team
3
2013
572
0.190
Why?
Heart-Assist Devices
2
2008
1093
0.190
Why?
Benchmarking
1
2022
146
0.180
Why?
Certification
2
2012
71
0.180
Why?
Coronary Circulation
2
2019
219
0.180
Why?
Heart Valves
1
2021
54
0.180
Why?
Middle Aged
17
2020
29264
0.180
Why?
Atrial Fibrillation
2
2019
695
0.180
Why?
Exercise
2
2020
869
0.170
Why?
Coronary Thrombosis
1
2000
35
0.170
Why?
Clinical Protocols
2
2020
245
0.170
Why?
Inferior Wall Myocardial Infarction
1
2020
8
0.170
Why?
Hospitals, Rural
1
2020
11
0.170
Why?
Peptides
2
2002
859
0.170
Why?
Aortic Valve Stenosis
3
2013
346
0.170
Why?
Rural Health
1
2020
51
0.170
Why?
Time Factors
5
2018
6577
0.170
Why?
Heart Failure
3
2022
2423
0.170
Why?
Marital Status
1
2020
32
0.170
Why?
Tobacco Use
1
2020
31
0.160
Why?
Antineoplastic Agents
1
2010
1850
0.160
Why?
Pregnancy Complications
1
2025
549
0.160
Why?
Protective Factors
1
2020
92
0.160
Why?
Patient Selection
3
2013
732
0.160
Why?
Cardiomyopathy, Hypertrophic
1
2021
158
0.160
Why?
Prasugrel Hydrochloride
2
2021
24
0.160
Why?
Sex Distribution
1
2020
330
0.150
Why?
Algorithms
2
2016
1731
0.150
Why?
Age Distribution
1
2020
444
0.150
Why?
Hemoglobins
1
2020
321
0.150
Why?
Hemodynamics
3
2022
870
0.150
Why?
Evidence-Based Practice
2
2016
116
0.150
Why?
Nutrition Surveys
1
2020
312
0.140
Why?
Ethics, Medical
1
2021
402
0.140
Why?
Vascular Diseases
1
2019
157
0.140
Why?
Coronavirus Infections
2
2020
383
0.140
Why?
Pneumonia, Viral
2
2020
394
0.140
Why?
Proportional Hazards Models
1
2022
1485
0.140
Why?
Ventricular Dysfunction, Left
2
2005
381
0.140
Why?
Predictive Value of Tests
5
2019
2297
0.140
Why?
Leadership
1
2020
244
0.140
Why?
Heart Ventricles
1
2022
799
0.140
Why?
Aged
12
2020
21641
0.140
Why?
Internet
1
2020
403
0.140
Why?
Forecasting
1
2019
376
0.140
Why?
Education, Medical, Graduate
2
2013
559
0.140
Why?
Atherectomy, Coronary
1
1997
10
0.140
Why?
Freedom
1
2017
18
0.130
Why?
Triage
1
2018
148
0.130
Why?
Delivery of Health Care
2
2020
676
0.130
Why?
Survival Analysis
3
2013
1596
0.130
Why?
Female
20
2025
71548
0.130
Why?
Ischemia
1
2020
384
0.130
Why?
Risk Reduction Behavior
1
2017
148
0.130
Why?
Heparin
3
2003
225
0.130
Why?
Physicians
2
2013
633
0.130
Why?
Emergency Medical Services
1
2020
414
0.130
Why?
Cholesterol, LDL
1
2020
604
0.130
Why?
Inpatients
1
2020
537
0.130
Why?
Multivariate Analysis
1
2020
1490
0.130
Why?
Drug-Eluting Stents
1
2016
70
0.130
Why?
Ascorbic Acid
1
1996
82
0.120
Why?
Antibodies, Monoclonal, Humanized
1
2020
553
0.120
Why?
Smoking Cessation
1
2017
209
0.120
Why?
Prospective Studies
4
2022
6576
0.120
Why?
Surgeons
1
2020
280
0.120
Why?
Blood Viscosity
1
1995
13
0.120
Why?
Pandemics
2
2020
1189
0.120
Why?
Diabetes Complications
1
1997
207
0.120
Why?
Biopsy
3
2007
1301
0.120
Why?
Coronary Vessels
2
2016
566
0.120
Why?
Lower Extremity
1
2017
188
0.120
Why?
Quality of Life
1
2025
2147
0.120
Why?
Status Asthmaticus
1
1995
20
0.120
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2022
757
0.120
Why?
Clinical Trials as Topic
4
2022
1154
0.120
Why?
Heart Function Tests
1
2014
58
0.110
Why?
Angina, Stable
1
2014
8
0.110
Why?
Endovascular Procedures
2
2013
775
0.110
Why?
Tachycardia, Supraventricular
1
2015
111
0.110
Why?
Congresses as Topic
1
2015
187
0.110
Why?
Chronic Disease
3
2025
1255
0.110
Why?
World Health Organization
1
2014
118
0.110
Why?
Quality of Health Care
2
2021
420
0.110
Why?
Thiophenes
1
2014
72
0.110
Why?
Cause of Death
2
2014
504
0.110
Why?
Phosphodiesterase 5 Inhibitors
1
2014
37
0.110
Why?
Hospitals, Veterans
2
2013
357
0.110
Why?
Survival Rate
2
2020
2211
0.110
Why?
Adenosine
1
2014
139
0.100
Why?
Exercise Therapy
1
1995
182
0.100
Why?
Severity of Illness Index
2
2018
3085
0.100
Why?
Equipment Design
3
2008
604
0.100
Why?
Myocardial Reperfusion
1
2013
74
0.100
Why?
Antioxidants
1
1996
377
0.100
Why?
Peripheral Arterial Disease
1
2017
312
0.100
Why?
Cardiovascular Agents
1
2014
91
0.100
Why?
Prevalence
1
2020
2658
0.100
Why?
Exercise Test
1
2014
264
0.100
Why?
Piperazines
1
2014
257
0.100
Why?
Cross-Over Studies
2
2012
330
0.100
Why?
Atherosclerosis
1
2020
999
0.100
Why?
Myocardium
2
2007
1045
0.100
Why?
Insulin Resistance
1
2017
695
0.100
Why?
Diagnostic Imaging
1
2014
317
0.100
Why?
Smoking
1
2017
1139
0.090
Why?
Blood Pressure
1
2017
1420
0.090
Why?
Program Development
1
2012
190
0.090
Why?
Hyperlipidemias
1
2013
198
0.090
Why?
Death, Sudden, Cardiac
1
2014
266
0.090
Why?
Hospitalization
2
2018
1892
0.090
Why?
Point-of-Care Systems
2
2003
193
0.090
Why?
American Cancer Society
1
2010
2
0.080
Why?
Syndrome
2
2003
1158
0.080
Why?
Adult
7
2020
31842
0.080
Why?
Gonadotropin-Releasing Hormone
1
2010
86
0.080
Why?
Obesity
2
2013
2429
0.080
Why?
Morbidity
1
2010
256
0.080
Why?
Animals
4
2020
36407
0.080
Why?
Consensus Development Conferences as Topic
1
2007
47
0.070
Why?
Endocardium
1
2007
56
0.070
Why?
Follow-Up Studies
4
2020
5461
0.070
Why?
Blood Coagulation Tests
2
2004
62
0.070
Why?
Electrodes, Implanted
1
2008
169
0.070
Why?
Magnetic Resonance Angiography
1
2008
168
0.070
Why?
Betacoronavirus
2
2020
304
0.070
Why?
Renal Insufficiency
1
2009
254
0.060
Why?
Myocarditis
1
2007
137
0.060
Why?
Clinical Decision-Making
2
2019
296
0.060
Why?
Terminology as Topic
1
2007
234
0.060
Why?
Pharmacists
1
2006
99
0.060
Why?
Pleural Effusion, Malignant
1
2005
12
0.060
Why?
Pacemaker, Artificial
1
2008
178
0.060
Why?
Cardiac Tamponade
1
2005
38
0.060
Why?
Young Adult
1
2020
9875
0.060
Why?
Aged, 80 and over
5
2019
7173
0.060
Why?
Radiography
1
2007
825
0.060
Why?
Defibrillators, Implantable
1
2008
198
0.060
Why?
Pyridines
1
2006
248
0.060
Why?
Pericardial Effusion
1
2005
71
0.060
Why?
Pharmacokinetics
1
2004
16
0.060
Why?
Antithrombin III
1
2004
26
0.060
Why?
Hematologic Agents
1
2003
7
0.050
Why?
Hemorrhage
2
2008
508
0.050
Why?
Health Planning Guidelines
1
2003
34
0.050
Why?
Echocardiography
3
2012
1125
0.050
Why?
Cardiomyopathies
1
2007
516
0.050
Why?
Coronary Stenosis
1
2003
82
0.050
Why?
Pulmonary Wedge Pressure
1
2022
52
0.050
Why?
Hospital Mortality
2
2020
1088
0.050
Why?
Angiography
2
2013
215
0.050
Why?
Kidney
1
2009
1418
0.050
Why?
Health Personnel
1
2006
540
0.050
Why?
Maryland
1
2021
35
0.050
Why?
Drug Monitoring
1
2003
181
0.050
Why?
Magnetic Resonance Imaging, Cine
2
2012
164
0.040
Why?
Thrombin
1
2001
62
0.040
Why?
Cardiotonic Agents
1
2022
144
0.040
Why?
Heart Transplantation
1
2007
895
0.040
Why?
Combined Modality Therapy
2
2010
1307
0.040
Why?
Hospital Costs
1
2002
187
0.040
Why?
Geography
1
2020
124
0.040
Why?
Vascular Patency
1
2000
198
0.040
Why?
Social Isolation
1
2020
48
0.040
Why?
Tomography, X-Ray Computed
3
2013
2173
0.040
Why?
Personal Protective Equipment
1
2020
55
0.040
Why?
Contrast Media
1
2003
513
0.040
Why?
Gastrointestinal Hemorrhage
1
2021
239
0.040
Why?
Infusions, Intravenous
1
2000
571
0.040
Why?
Administration, Oral
1
2021
727
0.040
Why?
Canada
1
2019
343
0.040
Why?
Asymptomatic Diseases
1
2019
87
0.040
Why?
Recovery of Function
1
2021
468
0.040
Why?
Education, Medical, Continuing
2
2012
145
0.040
Why?
Registries
1
2005
1569
0.040
Why?
Prosthesis Design
1
2021
660
0.040
Why?
Administration, Intravenous
1
2018
162
0.040
Why?
Adenocarcinoma
1
2005
1071
0.040
Why?
Hypoglycemic Agents
1
2022
488
0.040
Why?
Glucose
1
2022
923
0.030
Why?
Myocardial Reperfusion Injury
1
2018
155
0.030
Why?
Cost-Benefit Analysis
1
2020
562
0.030
Why?
Poverty
1
2020
437
0.030
Why?
Comorbidity
2
2014
1619
0.030
Why?
Sex Factors
1
2020
1384
0.030
Why?
Cohort Studies
2
2013
5190
0.030
Why?
Vasodilator Agents
1
1997
214
0.030
Why?
Classification
1
2015
19
0.030
Why?
Logistic Models
1
2020
1907
0.030
Why?
Healthcare Disparities
1
2020
479
0.030
Why?
Vasodilation
1
1996
181
0.030
Why?
Prognosis
2
2019
5076
0.030
Why?
Societies, Nursing
1
2014
3
0.030
Why?
Lung Neoplasms
1
2005
1787
0.030
Why?
Blood Vessel Prosthesis Implantation
1
2003
789
0.030
Why?
Telemedicine
1
2020
501
0.030
Why?
Age Factors
1
2020
2988
0.030
Why?
Foundations
1
2013
22
0.030
Why?
Aortic Diseases
1
2015
203
0.030
Why?
Incidence
1
2001
3399
0.030
Why?
Recurrence
1
1997
1468
0.030
Why?
Length of Stay
2
2013
1383
0.030
Why?
Nitric Oxide
1
1996
490
0.020
Why?
Patients
1
2013
127
0.020
Why?
Equipment Failure
1
2013
133
0.020
Why?
Factor Xa Inhibitors
2
2003
66
0.020
Why?
Minimally Invasive Surgical Procedures
1
2013
194
0.020
Why?
Pregnancy
1
2025
7529
0.020
Why?
Injections, Subcutaneous
1
2010
132
0.020
Why?
Risk
1
2012
834
0.020
Why?
Periodicals as Topic
1
2012
201
0.020
Why?
Retrospective Studies
2
2020
17402
0.020
Why?
Patient Safety
1
2013
431
0.020
Why?
Double-Blind Method
2
2003
1657
0.020
Why?
United States Department of Veterans Affairs
1
2012
704
0.020
Why?
Multicenter Studies as Topic
1
2008
289
0.020
Why?
Public Policy
1
2007
54
0.020
Why?
Creatinine
1
2009
429
0.020
Why?
Education, Nursing, Continuing
1
2006
18
0.020
Why?
International Cooperation
1
2007
167
0.020
Why?
Economics, Pharmaceutical
1
2003
9
0.010
Why?
Texas
1
2012
3693
0.010
Why?
Databases, Factual
1
2008
1241
0.010
Why?
Graft Rejection
1
2007
629
0.010
Why?
Whole Blood Coagulation Time
1
2003
14
0.010
Why?
Stroke Volume
1
2005
531
0.010
Why?
Body Mass Index
1
2008
1712
0.010
Why?
Clinical Laboratory Techniques
1
2003
151
0.010
Why?
Monitoring, Physiologic
1
2003
389
0.010
Why?
Dose-Response Relationship, Drug
1
2003
1735
0.010
Why?
Child
1
2007
25762
0.000
Why?
LEVINE's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (334)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_